| Característica |
Objectiu de la convocatòria
Highly innovative basic science
programs will be carefully considered, but priority will be given to “bench to bedside”
translational research
proposals with the potential to deliver near term benefit to patients.
|
Característiques principals
The award
funds may be used flexibly to advance the career and research efforts of the awardee.
Applicants need not be trained specifically in clinical
prostate cancer research. Young Investigators may be working in basic, translational, clinical,
population sciences, bioengineering or any other field that could contribute to the end of prostate
cancer. However, successful applicants should be working in a research environment capable of
supporting transformational prostate cancer
research.
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
|
Convocatòria (URL)
http://www.pcf.org/site/c.leJRIROrEpH/b.5849007/k.F70A/Open_RFAs.htm
On line apllications System: http://www.pcfscience.org/
|
Requisits
Applicant should be within six-years following completion of a professional degree or clinical
training such as
MD, PhD, MD-PhD, MPH, or equivalent.
Applicant may hold title of Senior Postdoctoral Fellow, Instructor, Research Associate,
Assistant Professor, or
equivalent.
Applicant should have received no more than $200,000 in current direct research funding from all
sources including institutional funds. Investigators who have specifically received young
investigator research support from the NCI, NIH, or DoD are still qualified and very much
encouraged to apply.
|
Dotació
$75,000 per year
|
Durada
3 years
|
Documentació
A three year research proposal no greater than ten (10) pages is required. PCF welcomes
preliminary data in the ten-pages of text but does not have a strict data requirement. One half page of the ten-page
proposal should describe how this research may benefit patients with advanced prostate cancer. The
ten-page limit applies only to the proposal and not to references, CV, or other supplemental
information.
Two letters of support indicating the applicant’s strengths and potential to become
an independent investigator at the end of the PCF Young Investigator Award are required: One from
the applicant’s Mentor; the second from the applicant’s Departmental Chairperson or Cancer Center
Director.
Letter from the applicant’s Departmental Chairperson demonstrating that “matching
in-kind support” is available in the form of dedicated space, institutional overhead,
institutional core research facilities, etc.
The applicant’s NIH short form CV.
|